These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

100 related articles for article (PubMed ID: 891126)

  • 1. [Action of injectable disopyramide phosphate in the emergency treatment of ventricular tachycardia].
    Valère PE; Guerot C; Castillo Fenoy A; Branvin E; Urbanczyk A; Tricot R
    Coeur Med Interne; 1977; 16(2):285-92. PubMed ID: 891126
    [No Abstract]   [Full Text] [Related]  

  • 2. [Effect of intravenous disopyramide in supraventricular paroxysmal tachycardia refractory to vagal maneuvers].
    Romero-Ayala LC; Soní J
    Arch Inst Cardiol Mex; 1983; 53(2):147-51. PubMed ID: 6882095
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Recurrent ventricular tachycardia in man: evaluation of disopyramide therapy by intracardiac electrical stimulation.
    Benditt DG; Pritchett EL; Wallace AG; Gallagher JJ
    Eur J Cardiol; 1979 Apr; 9(4):255-76. PubMed ID: 428417
    [No Abstract]   [Full Text] [Related]  

  • 4. [Therapy of ventricular tachyarrhythmia with disopyramid phosphate].
    Steinbrunn W; Mattmann H; Enrico JF; Engel U
    Schweiz Med Wochenschr; 1980 Jun; 110(24):953-7. PubMed ID: 7414314
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Use of intravenous disopyramide in 126 cases of cardiac rhythm disorders (author's transl)].
    Ducloux G; Faivre G; Perrin A; Raynaud R; Canicave JC; Fauchier JP; Groussin P; Loire R; Saulnier JP
    Ann Cardiol Angeiol (Paris); 1978; 27(4):297-302. PubMed ID: 80150
    [No Abstract]   [Full Text] [Related]  

  • 6. The antiarrhythmic efficacy of intravenous therapy with disopyramide phosphate.
    Deano DA; Wu D; Mautner RK; Sherman RH; Ehsani AI; Rosen KM
    Chest; 1977 May; 71(5):597-606. PubMed ID: 856558
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Correlation of disopyramide pharmacokinetics with efficacy in ventricular tachyarrhythmia.
    Rangno RE; Warnica W; Ogilvie RI; Kreeft J; Bridger E
    J Int Med Res; 1976; 4(1 Suppl):54-8. PubMed ID: 1026530
    [No Abstract]   [Full Text] [Related]  

  • 8. Efficacy of disopyramide phosphate in the treatment of refractory ventricular tachycardia.
    Vismara LA; Vera Z; Miller RR; Mason DT
    Am J Cardiol; 1977 Jun; 39(7):1027-34. PubMed ID: 326016
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Clinical studies of Norpace (Part V).
    Cook WR
    Angiology; 1975 Jan; 26(1 Pt 2):140-1. PubMed ID: 1115401
    [No Abstract]   [Full Text] [Related]  

  • 10. [Induction and termination of ventricular tachycardia by programmed electrical stimulation of heart--a case in which the effect of disopyramide phosphate was confirmed by the stimulation study (author's transl)].
    Komatsu C; Ishinaga T; Motoyama M; Marutani K; Teruya H; Nakayama M; Kuno A; Sato Y; Yoshimura S
    Kokyu To Junkan; 1981 Feb; 29(2):209-15. PubMed ID: 6789431
    [No Abstract]   [Full Text] [Related]  

  • 11. Efficacy of disopyramide phosphate in the treatment of refractory ventricular arrhythmias.
    Meyers DG; Mohiuddin SM
    Nebr Med J; 1980 May; 65(5):123-5. PubMed ID: 7383223
    [No Abstract]   [Full Text] [Related]  

  • 12. Treatment of recurrent sustained ventricular tachycardia with mexiletine and disopyramide. Control by programmed ventricular stimulation.
    Manz M; Steinbeck G; Nitsch J; Lüderitz B
    Br Heart J; 1983 Mar; 49(3):222-8. PubMed ID: 6830659
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Control of recurrent ventricular tachycardia in a case of mitral valve prolapse and arterial hypertension, using the combination of disopyramide and amiodarone].
    Romano M; Garbarini U; Cazzani E
    Clin Ter; 1982 Jun; 101(5):543-50. PubMed ID: 6751661
    [No Abstract]   [Full Text] [Related]  

  • 14. Muscular subaortic stenosis: hemodynamic and clinical improvement after disopyramide.
    Pollick C
    N Engl J Med; 1982 Oct; 307(16):997-9. PubMed ID: 7202121
    [No Abstract]   [Full Text] [Related]  

  • 15. [Antiarrhythmic actions of disopyramide phosphate in patients with paroxysmal supraventricular tachycardia (author's transl)].
    Satoh M; Sada T; Kuan-Min S; Kira Y; Sekine I; Okabe F; Ueda A; Ito T; Matsumoto S
    Kokyu To Junkan; 1981 May; 29(5):537-44. PubMed ID: 7313358
    [No Abstract]   [Full Text] [Related]  

  • 16. Adverse reaction to disopyramide.
    Dibble JB; Webster NR
    Postgrad Med J; 1979 Sep; 55(646):570-2. PubMed ID: 514940
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Acute termination of cardiac arrhythmias with intravenous disopyramide.
    Ee BK; Chia BL; Ng RA; Oh V; Tan AT; Choo M
    Singapore Med J; 1982 Aug; 23(4):185-90. PubMed ID: 7178900
    [No Abstract]   [Full Text] [Related]  

  • 18. Intravenous disopyramide in myocardial infarction: a haemodynamic study.
    Marrott PK; Nairn PL; Hill PD; Turner G; Sharman J
    N Z Med J; 1983 Jan; 96(723):4-7. PubMed ID: 6571755
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Effects of disopyramide phosphate in repetitive paroxysmal ventricular tachycardia].
    Katoh T; Sasaki Y; Tsuda T
    Kokyu To Junkan; 1982 Sep; 30(9):959-64. PubMed ID: 7178700
    [No Abstract]   [Full Text] [Related]  

  • 20. Disopyramide for cardiac arrhythmias in children.
    Ikram H; Chan W
    Med J Aust; 1978 Apr; 1(7):392. PubMed ID: 672728
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.